Abstract
Studies in the field of microarray technology have exploded onto the scene to delve into the unknown underlying mechanisms and pathways in molecular disease. Diseases of the cardio-vascular system, particularly those with unexplained molecular etiologies, such as heart failure, have more recently been investigated using array technology. Our laboratory has sought to examine gene expression profiles of human heart failure using a 10,000+ element cardio-vascular-based complementary DNA microarray constructed in-house, termed the “CardioChip.” Our studies have identified panels of genes, such as those encoding sarcomeric and cytoskeletal proteins, stress proteins, and Ca2+ regulators, that are differentially expressed in disease conditions as compared with samples from nonfailing hearts. Microarrays are effective tools for examining molecular portraits of the cardiovascular disease condition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Towbin, J. A. and Bowles, N. E. (2000) Genetic abnormalities responsible for dilated cardiomyopathy. Curr. Cardiol. Rep. 2, 475–480.
Hwang, J. J., Dzau, V. J., and Liew, C. C. (2001) Genomics and the pathophysiol-ogy of heart failure. Current Cardiol. Rep. 3, 198–207.
Jandreski, M. A. and Liew, C. C. (1987) Construction of a human ventricular cDNA library and characterization of a beta myosin heavy chain cDNA clone. Hum. Genet. 76, 47–53.
Liew, C. C. (1993) A human heart cDNA library—the development of an efficient and simple method for automated DNA sequencing. J. Mol. Cell. Cardiol. 25, 891–894.
Hwang, D. M., Hwang, W. S., and Liew, C. C. (1994) Single pass sequencing of a unidirectional human fetal heart cDNA library to discover novel genes of the cardiovascular system. J. Mol. Cell. Cardiol. 26, 1329–1333.
Hwang, D. M., Dempsey, A. A., Wang, R. X., et al. (1997) A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardio-vascular genes. Circulation 96, 4146–4203.
Liew, C. C., Hwang, D. M., Fung, Y. W., et al. (1994) A catalogue of genes in the cardiovascular system as identified by expressed sequence tags. Proc. Natl. Acad. Sci. USA 91, 10,645–10,649.
Barrans, J. D. (2002) Genomic Exploration of Cardiovascular-Based Gene Expression, PhD Thesis, University of Toronto, Department of Laboratory Medicine and Pathobiology.
Liew, C. C., Hwang, D. M., Wang, R. X., et al. (1997) Construction of a human heart cDNA library and identification of cardiovascular based genes (CVBest). Mol. Cell. Biochem. 172, 81–87.
Shalon, D., Smith, S. J., and Brown, P. O. (1996) A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridiza-tion. Genome Res. 6, 639–645.
DeRisi, J., Penland, L., Brown, P. O., et al. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14, 457–460.
Lau, W. Y., Lai, P. B., Leung, M. F., et al. (2000) Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis. Oncol. Res. 12, 59–69.
Wolf, M., El-Rifai, W., Tarkkanen, M., et al. (2000) Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. Cancer Genet. Cytogenet. 123, 128–132.
van’ t Veer, L. J., Dai, H., van de Vijver, M. J., et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536.
Mori, M., Mimori, K., Yoshikawa, Y., et al. (2002) Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 131(1 Suppl), S39–47.
Hippo, Y., Taniguchi, H., Tsutsumi, S., et al. (2002) Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 62, 233–240.
Alizadeh, A., Eisen, M., Davis, R. E., et al. (1999) The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb. Symp. Quant. Biol. 64, 71–78.
Alizadeh, A. A., Eisen, M. B., Davis, R. E., et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511.
Shipp, M. A., Ross, K. N., Tamayo, P., et al. (2002) Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8, 68–74.
Granjeaud, S., Nguyen, C., Rocha, D., Luton, R., and Jordan, B.R. (1996) From hybridization image to numerical values: a practical, high throughput quantifica-tion system for high density filter hybridizations. Genet. Anal. 12, 151–162.
Bertucci, F., Bernard, K., Loriod, B., et al. (1999) Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum. Mol. Genet. 8, 1715–1722.
Nguyen, C., Rocha, D., Granjeaud, S., et al. (1995) Differential gene expression in the murine thymus assayed by quantitative hybridization of arrayed cDNA clones. Genomics 29, 207–216.
Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. (1995) Quantitative moni-toring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470.
Lockhart, D. J. and Winzeler, E. A. (2000) Genomics, gene expression and DNA arrays. Nature 405, 827–836.
Bowtell, D. D. (1999) Options available—from start to finish—for obtaining expression data by microarray. Nat. Genet. 21(1 Suppl), 25–32.
Lipshutz, R. J., Fodor, S. P., Gingeras, T. R., and Lockhart, D. J. (1999) High density synthetic oligonucleotide arrays. Nat. Genet. 21(1 Suppl), 20–24.
Schena, M., Shalon, D., Heller, R., Chai, A., Brown, P. O., and Davis, R. W. (1996) Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. USA 93, 10,614–10,619.
Stanton, L. W., Garrard, L. J., Damm, D., et al. (2000) Altered patterns of gene expression in response to myocardial infarction. Circ. Res. 86, 939–945.
Yang, J., Moravec, C. S., Sussman, M. A., et al. (2000) Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102, 3046–3052.
Yang, J., Moravec, C. S., Sussman, M. A., et al. (2000) Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 97, 6745–6750.
Hanatani, A., Yoshiyama, M., Kim, S., et al. (1998) Assessment of cardiac function and gene expression at an early phase after myocardial infarction. Jpn. Heart J. 39, 375–388.
Mittmann, C., Munstermann, U., Weil, J., et al. (1998) Analysis of gene expression patterns in small amounts of human ventricular myocardium by a multiplex RNase protection assay. J. Mol. Med. 76, 133–140.
Lowes, B. D., Minobe, W., and Abraham, W. T. (1997) Changes in gene expression in the intact human heart: downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J. Clin. Invest. 100, 2315–2324.
Mendez, R. E., Pfeffer, J. M., Ortola, F. V., et al. (1987) Atrial natriuretic peptide transcription, storage, and release in rats with myocardial infarction. Am. J. Physiol. 253, H1449–1455.
Friddle, C. J., Koga, T., Rubin, E. M., et al. (2000) Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 97, 6745–6750.
Haase, D., Lehmann, M. H., Korner, M. M., et al. (2002) Identification and valida-tion of selective upregulation of ventricular myosin light chain type 2 mRNA in idiopathic dilated cardiomyopathy. Eur. J. Heart Fail. 4, 23–31.
Napoli, C., Lerman, L.O., Sica, V., Lerman, A., Tajana, G., and de Nigris, F. (2003) Microarray analysis: a novel research tool for cardiovascular scientists and physicians. Heart 89, 597–604.
Grzeskowiak, R., Witt, H., Drungowski, M., et al. (2003) Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc. Res. 59, 400–411.
Steenbergen, C., Afshari, C. A., Petrank, J. G., et al. Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure. Am. J. Physiol. Heart. Circ. Physiol. 284, H268–H276.
Kapoun, A. M., Liang, F., O’Young, G., et al. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts. Fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ. Res. 94, 453–461.
Chen, M. M., Ashley, E. A., Deng, D. X., et al. (2003) Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108, 1432–1439.
Barrans, J. D., Stamatiou, D., and Liew, C. C. (2001) Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. Biochem. Biophys. Res. Comm. 280, 964–969.
Barrans, J. D., Allen, P. D., Stamatiou, D., Dzau, V. J., and Liew, C. C. (2002) Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am. J. Path. 160, 2035–2043.
Hwang, J. J., Allen, P. D., Tsseng, G. C., et al. (2002) Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol. Genomics 10, 31–44.
Liew, C. C. and Dzau, V. (2004) Molecular genetics and genomics of heart failure. Nat. Rev. Genet. 5, 811–825.
Liew, C. C. (2005) Expressed genome molecular signatures of heart failure. Clin. Chem. Lab. Med. 43, 462–469.
Cunha-Neto, E., Dzau, V. J., Allen, P. D., et al. (2005) Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas disease cardiomyopathy. Am. J. Path. 167, 305–313.
Hwang, D. M., Dempsey, A. A., Lee, C. Y., and Liew, C. C. (2000) Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics 66, 1–14.
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. (1990) Basic local alignment search tool. J. Mol. Biol. 215, 403–410.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
David Barrans, J., Liew, CC. (2006). “Chip”ping Away at Heart Failure. In: Kearns-Jonker, M. (eds) Congenital Heart Disease. Methods in Molecular Medicine, vol 126. Humana Press. https://doi.org/10.1385/1-59745-088-X:157
Download citation
DOI: https://doi.org/10.1385/1-59745-088-X:157
Publisher Name: Humana Press
Print ISBN: 978-1-58829-375-6
Online ISBN: 978-1-59745-088-1
eBook Packages: Springer Protocols